Transgender- versus cisgender adults have an increased prevalence of cirrhosis but similar five-year survival.

Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the initiation of ...

A 69-year-old man from Arizona tragically died after developing an aggressive form of cancer from a liver transplant, a rare ...

Although comorbidity burden had no prognostic significance in patients with HCC, older age was significantly associated with worse overall survival.

Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to treating cardiometabolic diseases driven by obesity, today announced that Jayson Dallas, M.D., chief executive ...